Pharmaceutical News

RSS

Study reveals sharp increase in hospital encounters for benzodiazepine-related toxicity among youth

The rate of hospital encounters for benzodiazepine-related toxicity rose by 67 per cent for young adults (aged 19 to 24) and 44 per cent for youth (aged 18 or below) in Ontario between 2013 and 2020, according to a new study from ICES and Unity Health Toronto.

15 Jun 2023

Study examines the drivers of specialty drug diffusion

Researchers from McGill University and Ontario Tech University published a new Journal of Marketing article that examines the drivers of specialty drug diffusion.

15 Jun 2023

Being "not up-to-date" on COVID-19 vaccination linked to lower risk of infection, study suggests

Researchers investigate whether not “up-to-date” individuals had a higher risk of COVID-19 than “up-to-date” individuals.

14 Jun 2023

Landmark study in trauma care shines new light on tranexamic acid

A new study from Australia, New Zealand and Germany published in the New England Journal of Medicine raises important questions about the success or otherwise of emergency medicine.

14 Jun 2023

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug Company.

13 Jun 2023

Study reveals alarming pediatric antibiotic prescribing practices in Madagascar, Senegal, and Cambodia

In a recent article published in the journal PLOS Medicine, researchers performed a prospective, longitudinal study to estimate the proportion of outpatient consultations resulting in inappropriate antibiotic prescriptions in young children in three low- and middle-income countries (LMICs), Madagascar, Senegal, and Cambodia.

13 Jun 2023

COVID-19 vaccine hesitancy doesn't spill over to routine childhood vaccinations, US polls reveal

Media attention on COVID-19 vaccine hesitancy in the US raises concerns about the impact on routine childhood immunizations, with potential disruptions to vaccination rates and school-based requirements.

13 Jun 2023

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

In a recent article published in the journal JAMA Network, researchers performed a randomized clinical trial (RCT) to demonstrate the noninferiority of letermovir vs. valganciclovir for prophylaxis of cytomegalovirus (CMV) in adult CMV-seronegative kidney transplant recipients (KTRs) who received a kidney from a CMV-seropositive individual.

13 Jun 2023

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin, a widely available oral medication, reduces SARS-CoV-2 viral load by 3.6-fold in outpatient trial, offering a potential treatment option. Ivermectin and fluvoxamine show no significant virologic effect.

12 Jun 2023

Metformin reduces risk of long COVID by over 40%

Researchers discuss whether metformin, ivermectin, or fluvoxamine could reduce the risk of long COVID if administered shortly after infection.

12 Jun 2023

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called "orphan" drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration review.

12 Jun 2023

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

A new study examines hospitalization and mortality rates from COVID-19 before and after the rollout of the vaccine in England.

11 Jun 2023

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

9 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Scientists unlock virus-fighting power with synthetic nanobody platform

Discovery and validation of nanobodies, a promising class of biologics, for viral infection prevention and treatment, including anti-SARS-CoV-2 nanobodies with enhanced neutralization properties through synergistic pairing. The study demonstrates the potential of nanobodies in developing effective therapies against viral infections.

8 Jun 2023

Experimental drug may slow the progression of atherosclerosis

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

8 Jun 2023

Diabetes drug reduces alcohol drinking by more than half in rats

The medication semaglutide, which is currently used in the treatment of type 2 diabetes and obesity, might also be an effective medication for alcohol dependence.

7 Jun 2023

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the comfort of their home.

7 Jun 2023

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Orally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.

7 Jun 2023

CBD and EPA cream: Dynamic duo for youthful skin

A recent study examines the anti-aging potential of a new cream formulation that contains CBD and EPA.

6 Jun 2023

Previous
1
...
49
50
51
52
53
54
55
...
1433
Next

Pharmaceutical News

Study reveals sharp increase in hospital encounters for benzodiazepine-related toxicity among youth

Study examines the drivers of specialty drug diffusion

Being "not up-to-date" on COVID-19 vaccination linked to lower risk of infection, study suggests

Landmark study in trauma care shines new light on tranexamic acid

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Study reveals alarming pediatric antibiotic prescribing practices in Madagascar, Senegal, and Cambodia

COVID-19 vaccine hesitancy doesn't spill over to routine childhood vaccinations, US polls reveal

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin reduces risk of long COVID by over 40%

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

Common diabetes drug prevents the development of long COVID, study finds

Global trials could save lives by changing treatment procedure for cancer in the future

Scientists unlock virus-fighting power with synthetic nanobody platform

Experimental drug may slow the progression of atherosclerosis

Diabetes drug reduces alcohol drinking by more than half in rats

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

CBD and EPA cream: Dynamic duo for youthful skin

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News